CTCBIO Inc. (KOSDAQ:060590)
South Korea
· Delayed Price · Currency is KRW 3,910.00
+50.00 (1.30%)
At close: Apr 29, 2026
CTCBIO Revenue
In the year 2025, CTCBIO had annual revenue of 123.77B KRW with 3.25% growth. CTCBIO had revenue of 31.62B in the quarter ending December 31, 2025.
Revenue
123.77B
Revenue Growth
+3.25%
P/S Ratio
0.76
Revenue / Employee
499.07M
Employees
248
Market Cap
93.48B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 123.77B | 3.89B | 3.25% |
| Dec 31, 2024 | 119.88B | -18.00B | -13.06% |
| Dec 31, 2023 | 137.88B | -27.33B | -16.54% |
| Dec 31, 2022 | 165.21B | 24.89B | 17.74% |
| Dec 31, 2021 | 140.32B | 10.29B | 7.91% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Choong Ang Vaccine Laboratory | 39.19B |
| Quratis | 2.46B |
| SunBio,Inc. | 2.17B |
| CHA Vaccine Research Institute | 158.62M |
| TegoScience | 5.94B |
| KoBioLabs | 69.29B |
| Naturalendo Tech | 22.23B |
| Shaperon | 227.80M |